Brugnera Nunes de Mattos A, Maria Cerneski M, Reichert S, Nava Jaeger C. Use of Adalimumab, a TNF-Alpha Inhibitor, is Associated with Paradoxical Psoriasis: Two Clinical Case Reports . Braz J Case Rep. [Internet]. 2023 Jan. 27 [cited 2025 May 10];3(2):12-5. Available from: https://www.bjcasereports.com.br/index.php/bjcr/article/view/use_of_adalimumab_a_tnf_alpha_inhibitor